Document Detail


Psychotropic medications and the risk of sudden cardiac death during an acute coronary event.
MedLine Citation:
PMID:  21920969     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
AimsPsychotropic medication increases cardiac mortality, but the reasons for this association are not clear. We studied the role of psychotropic drugs as a triggering factor of sudden cardiac death (SCD) during an acute coronary event.Methods and resultsThe use of medication was compared between victims of SCD and survivors of an acute coronary event in a case-control study including a consecutive series of victims of SCD (n= 1814, mean age 65 ± 11 years) verified to be due to an acute coronary event at medico-legal autopsy and consecutive series of patients surviving an acute myocardial infarction (AMI; n= 1171, mean age 66 ± 12 years). The medication history was obtained from autopsy/hospital records and interviews with relatives of SCD victims and AMI patients. The use of antipsychotics [9.7 vs. 2.4%, odds ratio (OR) 4.4, 95% confidence interval (CI) 2.9-6.6; P< 0.001] and antidepressants (8.6 vs. 5.5%, OR: 1.6, 95% CI: 1.2-2.2; P= 0.003) was more common in the SCD than AMI group, but the use of benzodiazepines did not differ between the groups (11.7 vs. 13.2%; P= 0.270). The use of antipsychotics remained as a significant risk factor for SCD after adjustment for confounding variables (OR: 3.4, 95% CI: 1.8-6.5; P< 0.001). Combined use of phenothiazines and any antidepressant was associated with a very high risk of SCD (OR: 18.3, 95% CI: 2.5-135.3; P< 0.001).ConclusionThe use of psychotropic drugs, especially combined use of antipsychotic and antidepressant drugs, is strongly associated with an increased risk of SCD at the time of an acute coronary event.
Authors:
Jussi Honkola; Eeva Hookana; Sanna Malinen; Kari S Kaikkonen; M Juhani Junttila; Matti Isohanni; Marja-Leena Kortelainen; Heikki V Huikuri
Related Documents :
18226029 - Cardiac resynchronization therapy in pediatric and congenital heart disease.
16169379 - Reliability of ventricular remodeling as a surrogate for use in conjunction with clinic...
18574059 - Prognostic value and temporal behavior of the planar qrs-t angle in patients with nonis...
22683459 - Cardiac conduction block at multiple levels caused by arsenic trioxide therapy.
21039639 - Greater three-dimensional ventricular lead tip separation is associated with improved o...
21516439 - End-systolic versus end-diastolic late gadolinium enhanced imaging for the assessment o...
7553819 - Timing, mode, and predictors of death after direct angioplasty for acute myocardial inf...
10190399 - Outcome of target sites escaping high-grade (>70%) restenosis after percutaneous transl...
19519369 - Expressions of enos3 and ve-cadherin in microvascular endothelium at 7-day of reperfuse...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-9-14
Journal Detail:
Title:  European heart journal     Volume:  -     ISSN:  1522-9645     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-9-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Internal Medicine, Institute of Clinical Medicine, University of Oulu, PO Box 5000, Oulu 90014, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Gender differences in symptoms of myocardial ischaemia.
Next Document:  Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous c...